Skip to main content
JINLING PHARMACEUTICAL CO.,LTD logo

JINLING PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 000919 ISIN · CNE0000010W5 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,771 across all filing types
Latest filing 2020-05-29 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 000919

About JINLING PHARMACEUTICAL CO.,LTD

https://www.jlyy1999.com

Jinling Pharmaceutical Co., Ltd. specializes in the research, development, manufacture, and sale of pharmaceutical products, with a focus on chemical drugs and traditional Chinese medicine preparations. The company’s product portfolio primarily targets cardiovascular and cerebrovascular diseases, anti-tumor treatments, and digestive system health. A prominent product in its lineup is the Mailuoning Injection, utilized for treating various vascular conditions. In addition to its manufacturing operations, the company is involved in the management and operation of medical institutions, integrating clinical services with pharmaceutical production. Its business model emphasizes the synergy between drug development and healthcare service delivery to provide integrated medical solutions.

Recent filings

Filing Released Lang Actions
公司章程（2020年5月）
Governance Information Classification · 100% confidence The document is the Articles of Association (章程) of Jinling Pharmaceutical Company Limited, detailing the company's organizational structure, shareholder rights, board of directors, management, financial accounting, and other governance matters. It includes extensive provisions on shareholder meetings, board responsibilities, and company operations. This type of document is a governance document that outlines the internal rules and governance practices of the company. It is not a financial report, earnings release, or announcement. Therefore, the appropriate classification is Governance Information (CGR). The document length and content confirm it is the full governance charter, not an announcement or summary.
2020-05-29 Chinese
独立董事候选人声明（王广基）
Board/Management Information Classification · 95% confidence The document is a formal declaration by an independent director candidate of a company, confirming compliance with various legal and regulatory requirements for serving as an independent director. It includes detailed statements about qualifications, independence, and adherence to relevant laws and regulations. There are no financial statements, earnings data, or report summaries. The document is not a report itself but a declaration related to board/management information, specifically about a candidate for the board of directors. Therefore, it fits best under the category of Board/Management Information (MANG). The document length and content support this classification with high confidence.
2020-05-29 Chinese
独立董事提名人声明（三）
Board/Management Information Classification · 95% confidence The document is a public statement from the board of directors nominating an independent director candidate for the company's board. It details the qualifications, compliance with regulatory requirements, and declarations regarding the nominee's independence and eligibility. There are no financial statements, earnings data, or report attachments. The content focuses on board/management information, specifically about a director nomination. Therefore, the document fits the category of Board/Management Information (MANG). The document length (7033 characters) supports it being a full statement rather than a brief announcement.
2020-05-29 Chinese
监事会议事规则修订对照表
Governance Information Classification · 95% confidence The document is a comparison table showing revisions to the Supervisory Committee Meeting Rules of Jinling Pharmaceutical Co., Ltd. It details changes in the powers and responsibilities of the Supervisory Committee, including oversight of company reports and financial audits. The content is about governance rules and internal supervisory procedures rather than financial results, audit reports, or announcements. It does not contain financial data or report publication announcements. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2020-05-29 Chinese
董事会议事规则（2020年5月）
Governance Information Classification · 100% confidence The document is titled '金陵药业股份有限公司董事会议事规则' which translates to 'Rules of Procedure for the Board of Directors of Jinling Pharmaceutical Co., Ltd.' It details the internal rules, procedures, powers, and responsibilities of the company's board of directors, including meeting organization, decision-making processes, voting rules, and post-meeting follow-up. There is no financial data, earnings information, or regulatory filings content. The document is a governance-related document outlining board structure and governance practices. Therefore, it fits the category of Governance Information (CGR). The document length is sufficient and it is not an announcement or a brief notice but a full set of rules, confirming it is the report itself, not an announcement.
2020-05-29 Chinese
股东大会议事规则修订对照表
Governance Information Classification · 95% confidence The document is a detailed comparison table showing revisions to the rules governing the shareholders' meetings of Jinling Pharmaceutical Co., Ltd. It includes references to the company's articles of association, relevant laws, and regulations about shareholder meetings. The content focuses on governance rules and procedures for shareholder meetings rather than financial results, audit opinions, or announcements of voting outcomes. The document is not a report of voting results, nor is it a proxy solicitation or a presentation. It is a governance-related document detailing internal rules and procedures for shareholder meetings, which fits the Governance Information (CGR) category. The document length is 2310 characters, which is relatively short but contains substantive content about governance rules, not just an announcement or notice. Therefore, the appropriate classification is Governance Information (CGR).
2020-05-29 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.